Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 20;7(24):4420-4425.
doi: 10.3889/oamjms.2019.874. eCollection 2019 Dec 30.

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors

Thuy Luu Quang  1 , Huyen Nguyen Thi Thu  1 , Kinh Nguyen Quoc  1 , Ha Nguyen Thu  2 , Dong Pham Van  3 , Nguyen Le Bao Tien  4 , Vo Van Thanh  4   5 , Vu Thi Nga  6 , Chu Dinh Toi  7
Affiliations

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors

Thuy Luu Quang et al. Open Access Maced J Med Sci. .

Abstract

Backround: The reversation of NMBA (neuromuscular blocking agents) prevents numerous postoperative complications, increases quality of recovery and decreases the time, expenditure spending in hospital. The choice of medicine used to reverse NMBA depends considered as a key fators to gain the best outcome and to avoid the side effects.

Aim: To evaluate the postoperative effect on muscle relaxation reversal and side effects of sugammadex 2 mg/kg versus the combination of neostigmine and atropine sulfate in the living kidney donors.

Methods: A randomised controlled trial on 70 patients undergoing living kidney donation surgery were allocated to 2 groups. Patients in group I (SUGA) were reversed with sugammadex 2 mg/kg and in group II (NEO/ATR) with the combination of neostigmine and atropine sulfat.

Results: With 35 patients in each group, the study results showed that after 3 mintutes of reversal patients reaching TOF value ≥ 0.9 in group SUGA is 91.4%, after 5 minutes 100% of patients in group SUGA reached TOF value ≥ 0.9 . In group NEO/ATR after 3 minutes 28.6% patients reached TOF ≥ 0.9 and 40% patients reached TOF≥ 0.9 after 5 minutes. The difference in percentage of patients reaching TOF ≥ 0.9 after 3 minutes, 5 minutes of reversal between two groups is significant (p<0.05). After 10 minutes, 100% patients in both group got TOF ≥ 0.9. Time to exutubation of group SUGA was 249.43 ± 81.75 seconds and it was 456.29 ± 146.45 seconds in group NEO/ATR. Nausea, bradycardia, and increased phlegm production in group NEO/ATR was 22.9%; 28.5%; 25.7% respectively; while those side effects were not met in group SUGA, the difference was significant (p<0.05).

Conclusion: The muscle relaxation reversal effect of sugammadex was faster than that of neostigmine, the duration TOF ≥ 0.9 and the time to extubation was significantly faster. Sugammadex did not cause hemodynamic changes before and after muscle relaxation reversal, neostigmine resulted in the bradycardia, increased phlegm secreting and other side effects. The renal function after 24 hours postoperatively of two groups was similar.

Keywords: living kidney donors; muscle relaxants; sugammadex.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The ratio reaches TOF 0.7 after reversal of NMBAs over time
Figure 2
Figure 2
The ratio reaches TOF ≥ 0.9 after reversal of NMBAs over time
See this image and copyright information in PMC

References

    1. Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade:a meta-analysis of randomized controlled trials. Journal of clinical anesthesia. 2016;35:1–2. https://doi.org/10.1016/j.jclinane.2016.06.018 PMid:27∋04. - PubMed
    1. Kim KS, Cheong MA, Lee HJ, Lee JM. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesthesia &Analgesia. 2004;99(4):1080–5. https://doi.org/10.1213/01.ANE.0000130616.57678.80 PMid:15385354. - PubMed
    1. Donati F. Neuromuscular MonitoringMore than Meets the Eye. Anesthesiology:The Journal of the American Society of Anesthesiologists. 2012;117(5):934–6. https://doi.org/10.1097/ALN.0b013e31826f9143 PMid:23011318. - PubMed
    1. Kopman AF, Kopman DJ, Ng J, Zank LM. Antagonism of profound cisatracurium and rocuronium block:the role of objective assessment of neuromuscular function. Journal of clinical anesthesia. 2005;17(1):30–5. https://doi.org/10.1016/j.jclinane.2004.03.009 PMid:15721727. - PubMed
    1. Bevan JC, Collins L, Fowler C, Kahwaji R, Rosen HD, Smith MF, Scheepers LD, Stephenson CA, Bevan DR. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesthesia &Analgesia. 1999;89(2):333–9. https://doi.org/10.1213/00000539-199908000-00016. - PubMed

LinkOut - more resources